The use of mesenchymal (skeletal) stem cells for treatment of degenerative diseases: Current status and future perspectives

89Citations
Citations of this article
66Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Human bone marrow derived-mesenchymal (skeletal) stem (MSC) cells are a group of non-hematopoietic stem cells residing in the perivascular niches in bone marrow. These cells have the capacity to differentiate mainly into mesoderm-type cells such as osteoblasts, chondrocytes and adipocytes and possibly but not proven to non-mesodermal cell types. Recently, there has been an increased interest in understanding the biology of MSC due to their potential use in cell-based therapy for multiple degenerative diseases. Here, we will provide an update on the current status of these novel therapeutic opportunities. © 2008 Wiley-Liss, Inc.

Cite

CITATION STYLE

APA

Abdallah, B. M., & Kassem, M. (2009, January). The use of mesenchymal (skeletal) stem cells for treatment of degenerative diseases: Current status and future perspectives. Journal of Cellular Physiology. https://doi.org/10.1002/jcp.21572

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free